GlassScriptPhysician profile
Fadi Chalhoub
NPI 1134307937
$29,170.14
in general payments reported to CMS, 2019-2025
12 companies · $3,767 in 2025
The $3,767 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,255 · 2020: $1,889 · 2021: $4,901 · 2022: $3,976 · 2023: $6,544 · 2024: $4,838 · 2025: $3,767.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $3,774.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,375.44 |
| Travel and Lodging | $3,774.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,467.60 | 2021-2025 | Micra, Azure Xt Dr Mri Surescan, Linq II |
| Abbott Laboratories | $7,029.57 | 2019-2025 | Aveir, Gallant, Assurity |
| Medtronic Vascular, INC. | $3,781.68 | 2019-2020 | |
| Biotronik INC. | $3,138.71 | 2019-2025 | Acticor 7 Vr-T Dx, Amvia Edge |
| Biosense Webster, INC. | $1,845.69 | 2019-2025 | Carto 3 |
| Boston Scientific Corporation | $1,770.04 | 2019-2025 | Farapulse, General - Therapies, S-Icd System Magnet |
| Janssen Pharmaceuticals, INC | $442.23 | 2020-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $215.11 | 2020-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $195.77 | 2020 | |
| Impulse Dynamics (USA) INC. | $138.99 | 2023 | Optimizer |
| Cardiva Medical, INC. | $76.35 | 2022 | |
| Zoll Respicardia, INC. | $68.40 | 2023 | Remede System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fadi Chalhoub listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.